Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Delayed cellulitis associated with conservative therapy for breast cancer

Identifieur interne : 000A96 ( PascalFrancis/Corpus ); précédent : 000A95; suivant : 000A97

Delayed cellulitis associated with conservative therapy for breast cancer

Auteurs : S. R. Miller ; T. Mondry ; J. S. Reed ; A. Findley ; P. A. S. Johnstone

Source :

RBID : Pascal:98-0265253

Descripteurs français

English descriptors

Abstract

Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0022-4790
A02 01      @0 JSONAU
A03   1    @0 J. surg. oncol.
A05       @2 67
A06       @2 4
A08 01  1  ENG  @1 Delayed cellulitis associated with conservative therapy for breast cancer
A11 01  1    @1 MILLER (S. R.)
A11 02  1    @1 MONDRY (T.)
A11 03  1    @1 REED (J. S.)
A11 04  1    @1 FINDLEY (A.)
A11 05  1    @1 JOHNSTONE (P. A. S.)
A14 01      @1 Breast Health Center, Naval Medical Center @2 San Diego, California @3 USA @Z 1 aut. @Z 2 aut. @Z 3 aut. @Z 4 aut. @Z 5 aut.
A14 02      @1 Surgical Oncology Division, Naval Medical Center @2 San Diego, California @3 USA @Z 4 aut.
A14 03      @1 Radiation Oncology Division, University of California @2 San Diego, California @3 USA @Z 5 aut.
A20       @1 242-245
A21       @1 1998
A23 01      @0 ENG
A43 01      @1 INIST @2 14855 @5 354000075837850060
A44       @0 0000 @1 © 1998 INIST-CNRS. All rights reserved.
A45       @0 11 ref.
A47 01  1    @0 98-0265253
A60       @1 P
A61       @0 A
A64   1    @0 Journal of surgical oncology
A66 01      @0 USA
C01 01    ENG  @0 Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.
C02 01  X    @0 002B25K
C02 02  X    @0 002B26L
C03 01  X  FRE  @0 Tumeur maligne @5 01
C03 01  X  ENG  @0 Malignant tumor @5 01
C03 01  X  SPA  @0 Tumor maligno @5 01
C03 02  X  FRE  @0 Glande mammaire @5 02
C03 02  X  ENG  @0 Mammary gland @5 02
C03 02  X  SPA  @0 Glándula mamaria @5 02
C03 03  X  FRE  @0 Femelle @5 03
C03 03  X  ENG  @0 Female @5 03
C03 03  X  SPA  @0 Hembra @5 03
C03 04  X  FRE  @0 Homme @5 04
C03 04  X  ENG  @0 Human @5 04
C03 04  X  SPA  @0 Hombre @5 04
C03 05  X  FRE  @0 Chirurgie conservatrice @5 05
C03 05  X  ENG  @0 Conservative surgery @5 05
C03 05  X  SPA  @0 Cirugía conservatriz @5 05
C03 06  X  FRE  @0 Complication @5 06
C03 06  X  ENG  @0 Complication @5 06
C03 06  X  SPA  @0 Complicación @5 06
C03 07  X  FRE  @0 Cellulite @5 07
C03 07  X  ENG  @0 Cellulitis @5 07
C03 07  X  SPA  @0 Celulitis @5 07
C03 08  X  FRE  @0 Postopératoire @5 08
C03 08  X  ENG  @0 Postoperative @5 08
C03 08  X  SPA  @0 Postoperatorio @5 08
C03 09  X  FRE  @0 Radiothérapie @5 09
C03 09  X  ENG  @0 Radiotherapy @5 09
C03 09  X  SPA  @0 Radioterapia @5 09
C03 10  X  FRE  @0 Lymphoedème @5 10
C03 10  X  ENG  @0 Lymphedema @5 10
C03 10  X  SPA  @0 Linfedema @5 10
C03 11  X  FRE  @0 Expérience professionnelle @5 11
C03 11  X  ENG  @0 Professional experience @5 11
C03 11  X  SPA  @0 Experiencia profesional @5 11
C03 12  X  FRE  @0 Etats Unis @2 NG @5 12
C03 12  X  ENG  @0 United States @2 NG @5 12
C03 12  X  GER  @0 Vereinigte Staaten @2 NG @5 12
C03 12  X  SPA  @0 Estados Unidos @2 NG @5 12
C03 13  X  FRE  @0 Californie @2 NG @5 13
C03 13  X  ENG  @0 California @2 NG @5 13
C03 13  X  SPA  @0 California @2 NG @5 13
C07 01  X  FRE  @0 Amérique du Nord @2 NG
C07 01  X  ENG  @0 North America @2 NG
C07 01  X  GER  @0 Nordamerika @2 NG
C07 01  X  SPA  @0 America del norte @2 NG
C07 02  X  FRE  @0 Amérique @2 NG
C07 02  X  ENG  @0 America @2 NG
C07 02  X  SPA  @0 America @2 NG
C07 03  X  FRE  @0 Glande mammaire pathologie @5 37
C07 03  X  ENG  @0 Mammary gland diseases @5 37
C07 03  X  SPA  @0 Glándula mamaria patología @5 37
C07 04  X  FRE  @0 Peau pathologie @5 53
C07 04  X  ENG  @0 Skin disease @5 53
C07 04  X  SPA  @0 Piel patología @5 53
C07 05  X  FRE  @0 Tissu adipeux pathologie @5 54
C07 05  X  ENG  @0 Adipose tissue disorders @5 54
C07 05  X  SPA  @0 Tejido adiposo patología @5 54
C07 06  X  FRE  @0 Appareil circulatoire pathologie @5 61
C07 06  X  ENG  @0 Cardiovascular disease @5 61
C07 06  X  SPA  @0 Aparato circulatorio patología @5 61
C07 07  X  FRE  @0 Lymphatique pathologie @5 62
C07 07  X  ENG  @0 Lymphatic vessel disease @5 62
C07 07  X  SPA  @0 Linfático patología @5 62
N21       @1 173

Format Inist (serveur)

NO : PASCAL 98-0265253 INIST
ET : Delayed cellulitis associated with conservative therapy for breast cancer
AU : MILLER (S. R.); MONDRY (T.); REED (J. S.); FINDLEY (A.); JOHNSTONE (P. A. S.)
AF : Breast Health Center, Naval Medical Center/San Diego, California/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Surgical Oncology Division, Naval Medical Center/San Diego, California/Etats-Unis (4 aut.); Radiation Oncology Division, University of California/San Diego, California/Etats-Unis (5 aut.)
DT : Publication en série; Niveau analytique
SO : Journal of surgical oncology; ISSN 0022-4790; Coden JSONAU; Etats-Unis; Da. 1998; Vol. 67; No. 4; Pp. 242-245; Bibl. 11 ref.
LA : Anglais
EA : Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.
CC : 002B25K; 002B26L
FD : Tumeur maligne; Glande mammaire; Femelle; Homme; Chirurgie conservatrice; Complication; Cellulite; Postopératoire; Radiothérapie; Lymphoedème; Expérience professionnelle; Etats Unis; Californie
FG : Amérique du Nord; Amérique; Glande mammaire pathologie; Peau pathologie; Tissu adipeux pathologie; Appareil circulatoire pathologie; Lymphatique pathologie
ED : Malignant tumor; Mammary gland; Female; Human; Conservative surgery; Complication; Cellulitis; Postoperative; Radiotherapy; Lymphedema; Professional experience; United States; California
EG : North America; America; Mammary gland diseases; Skin disease; Adipose tissue disorders; Cardiovascular disease; Lymphatic vessel disease
GD : Vereinigte Staaten
SD : Tumor maligno; Glándula mamaria; Hembra; Hombre; Cirugía conservatriz; Complicación; Celulitis; Postoperatorio; Radioterapia; Linfedema; Experiencia profesional; Estados Unidos; California
LO : INIST-14855.354000075837850060
ID : 98-0265253

Links to Exploration step

Pascal:98-0265253

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Delayed cellulitis associated with conservative therapy for breast cancer</title>
<author>
<name sortKey="Miller, S R" sort="Miller, S R" uniqKey="Miller S" first="S. R." last="Miller">S. R. Miller</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mondry, T" sort="Mondry, T" uniqKey="Mondry T" first="T." last="Mondry">T. Mondry</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Reed, J S" sort="Reed, J S" uniqKey="Reed J" first="J. S." last="Reed">J. S. Reed</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Findley, A" sort="Findley, A" uniqKey="Findley A" first="A." last="Findley">A. Findley</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Surgical Oncology Division, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Johnstone, P A S" sort="Johnstone, P A S" uniqKey="Johnstone P" first="P. A. S." last="Johnstone">P. A. S. Johnstone</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Radiation Oncology Division, University of California</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">98-0265253</idno>
<date when="1998">1998</date>
<idno type="stanalyst">PASCAL 98-0265253 INIST</idno>
<idno type="RBID">Pascal:98-0265253</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000A96</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Delayed cellulitis associated with conservative therapy for breast cancer</title>
<author>
<name sortKey="Miller, S R" sort="Miller, S R" uniqKey="Miller S" first="S. R." last="Miller">S. R. Miller</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Mondry, T" sort="Mondry, T" uniqKey="Mondry T" first="T." last="Mondry">T. Mondry</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Reed, J S" sort="Reed, J S" uniqKey="Reed J" first="J. S." last="Reed">J. S. Reed</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Findley, A" sort="Findley, A" uniqKey="Findley A" first="A." last="Findley">A. Findley</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="02">
<s1>Surgical Oncology Division, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Johnstone, P A S" sort="Johnstone, P A S" uniqKey="Johnstone P" first="P. A. S." last="Johnstone">P. A. S. Johnstone</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
<affiliation>
<inist:fA14 i1="03">
<s1>Radiation Oncology Division, University of California</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Journal of surgical oncology</title>
<title level="j" type="abbreviated">J. surg. oncol.</title>
<idno type="ISSN">0022-4790</idno>
<imprint>
<date when="1998">1998</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Journal of surgical oncology</title>
<title level="j" type="abbreviated">J. surg. oncol.</title>
<idno type="ISSN">0022-4790</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>California</term>
<term>Cellulitis</term>
<term>Complication</term>
<term>Conservative surgery</term>
<term>Female</term>
<term>Human</term>
<term>Lymphedema</term>
<term>Malignant tumor</term>
<term>Mammary gland</term>
<term>Postoperative</term>
<term>Professional experience</term>
<term>Radiotherapy</term>
<term>United States</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Tumeur maligne</term>
<term>Glande mammaire</term>
<term>Femelle</term>
<term>Homme</term>
<term>Chirurgie conservatrice</term>
<term>Complication</term>
<term>Cellulite</term>
<term>Postopératoire</term>
<term>Radiothérapie</term>
<term>Lymphoedème</term>
<term>Expérience professionnelle</term>
<term>Etats Unis</term>
<term>Californie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0022-4790</s0>
</fA01>
<fA02 i1="01">
<s0>JSONAU</s0>
</fA02>
<fA03 i2="1">
<s0>J. surg. oncol.</s0>
</fA03>
<fA05>
<s2>67</s2>
</fA05>
<fA06>
<s2>4</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Delayed cellulitis associated with conservative therapy for breast cancer</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>MILLER (S. R.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>MONDRY (T.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>REED (J. S.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>FINDLEY (A.)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>JOHNSTONE (P. A. S.)</s1>
</fA11>
<fA14 i1="01">
<s1>Breast Health Center, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Surgical Oncology Division, Naval Medical Center</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Radiation Oncology Division, University of California</s1>
<s2>San Diego, California</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA20>
<s1>242-245</s1>
</fA20>
<fA21>
<s1>1998</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>14855</s2>
<s5>354000075837850060</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1998 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>11 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>98-0265253</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i2="1">
<s0>Journal of surgical oncology</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B25K</s0>
</fC02>
<fC02 i1="02" i2="X">
<s0>002B26L</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Tumeur maligne</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Malignant tumor</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Tumor maligno</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Glande mammaire</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Mammary gland</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Glándula mamaria</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Femelle</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Female</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Hembra</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Homme</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Human</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Hombre</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Chirurgie conservatrice</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Conservative surgery</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Cirugía conservatriz</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Complication</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Complication</s0>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Complicación</s0>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Cellulite</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Cellulitis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Celulitis</s0>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Postopératoire</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Postoperative</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Postoperatorio</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Radiothérapie</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Radiotherapy</s0>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Radioterapia</s0>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Lymphoedème</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Lymphedema</s0>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Linfedema</s0>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Expérience professionnelle</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Professional experience</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Experiencia profesional</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Etats Unis</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>United States</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="GER">
<s0>Vereinigte Staaten</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Estados Unidos</s0>
<s2>NG</s2>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>Californie</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>California</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>California</s0>
<s2>NG</s2>
<s5>13</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Amérique du Nord</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>North America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="GER">
<s0>Nordamerika</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>America del norte</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Amérique</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>America</s0>
<s2>NG</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Glande mammaire pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Mammary gland diseases</s0>
<s5>37</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Glándula mamaria patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Peau pathologie</s0>
<s5>53</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Skin disease</s0>
<s5>53</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Piel patología</s0>
<s5>53</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Tissu adipeux pathologie</s0>
<s5>54</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Adipose tissue disorders</s0>
<s5>54</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Tejido adiposo patología</s0>
<s5>54</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Appareil circulatoire pathologie</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Cardiovascular disease</s0>
<s5>61</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Aparato circulatorio patología</s0>
<s5>61</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Lymphatique pathologie</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Lymphatic vessel disease</s0>
<s5>62</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Linfático patología</s0>
<s5>62</s5>
</fC07>
<fN21>
<s1>173</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 98-0265253 INIST</NO>
<ET>Delayed cellulitis associated with conservative therapy for breast cancer</ET>
<AU>MILLER (S. R.); MONDRY (T.); REED (J. S.); FINDLEY (A.); JOHNSTONE (P. A. S.)</AU>
<AF>Breast Health Center, Naval Medical Center/San Diego, California/Etats-Unis (1 aut., 2 aut., 3 aut., 4 aut., 5 aut.); Surgical Oncology Division, Naval Medical Center/San Diego, California/Etats-Unis (4 aut.); Radiation Oncology Division, University of California/San Diego, California/Etats-Unis (5 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Journal of surgical oncology; ISSN 0022-4790; Coden JSONAU; Etats-Unis; Da. 1998; Vol. 67; No. 4; Pp. 242-245; Bibl. 11 ref.</SO>
<LA>Anglais</LA>
<EA>Background and Objectives: Delayed breast cellulitis is an infrequently reported entity after conservation therapy for breast cancer. We describe our experience with this entity at Naval Medical Center, San Diego. Methods: Eight patients who presented with delayed cellulitis after wide local excision/axillary dissection and breast radiotherapy (RT) are presented. Their clinical characteristics and therapy are described and possible causative factors are analyzed. Results: The latency of breast cellulitis is variable after breast conservation therapy, although most cases in our experience and in the literature occur within a year post-RT. These infections are frequently refractory to a single course of antibiotics (n = 4 cases in our experience). Some patients suffer multiple episodes separated by months. Conclusions: Breast cancer patients are at risk for delayed cellulitis after conservative surgery and RT. The mechanism of such events probably involves lymph stasis, however. therapy is no different from the more frequently occurring cases of cellulitis presenting perioperatively.</EA>
<CC>002B25K; 002B26L</CC>
<FD>Tumeur maligne; Glande mammaire; Femelle; Homme; Chirurgie conservatrice; Complication; Cellulite; Postopératoire; Radiothérapie; Lymphoedème; Expérience professionnelle; Etats Unis; Californie</FD>
<FG>Amérique du Nord; Amérique; Glande mammaire pathologie; Peau pathologie; Tissu adipeux pathologie; Appareil circulatoire pathologie; Lymphatique pathologie</FG>
<ED>Malignant tumor; Mammary gland; Female; Human; Conservative surgery; Complication; Cellulitis; Postoperative; Radiotherapy; Lymphedema; Professional experience; United States; California</ED>
<EG>North America; America; Mammary gland diseases; Skin disease; Adipose tissue disorders; Cardiovascular disease; Lymphatic vessel disease</EG>
<GD>Vereinigte Staaten</GD>
<SD>Tumor maligno; Glándula mamaria; Hembra; Hombre; Cirugía conservatriz; Complicación; Celulitis; Postoperatorio; Radioterapia; Linfedema; Experiencia profesional; Estados Unidos; California</SD>
<LO>INIST-14855.354000075837850060</LO>
<ID>98-0265253</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000A96 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000A96 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:98-0265253
   |texte=   Delayed cellulitis associated with conservative therapy for breast cancer
}}

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024